Xin Lang Cai Jing·2025-12-15 22:18Group 1: Tesla - Tesla's stock rose by 3.56%, reaching a nearly one-year high with a trading volume of $54.109 billion [1][7] - The company is piloting a Robotaxi service in Austin without a safety driver, confirming the shift towards autonomous driving [1][8] - Wedbush predicts Tesla's market value will reach $3 trillion by the end of 2026, with Full Self-Driving (FSD) penetration potentially exceeding 50% [1][8] - Analyst Dan Ives states that Tesla is advancing towards an "AI revolution," with autonomous driving and robotics as core focus areas by 2026 [1][8] Group 2: Nvidia - Nvidia's stock increased by 0.73%, with a trading volume of $28.936 billion [1][10] - The company announced the launch of its new flagship open-source model series, Nemotron 3, which boasts improvements in speed, cost-effectiveness, and intelligence [1][10] Group 3: Broadcom - Broadcom's stock fell by 5.59%, with a trading volume of $22.525 billion, marking a three-day cumulative decline of 17.7% [2][9] - CICC maintains an "outperform" rating for Broadcom, with a target price of $475, citing strong AI ASIC revenue and a backlog of $73 billion [2][9] - The firm has raised its earnings forecast for FY26/FY27 due to increased visibility in revenue from AI computing and networking [2][9] Group 4: Amazon and Meta Platforms - Amazon's stock declined by 1.61%, with a trading volume of $10.253 billion, marking three consecutive days of decline [3][10] - Meta Platforms' stock rose by 0.59%, with a trading volume of $9.842 billion; the company is offering up to $100 million in signing bonuses for engineers and $250 million for top AI researchers [3][10] Group 5: Oracle - Oracle's stock decreased by 2.66%, with a trading volume of $8.047 billion; the company is facing scrutiny over its aggressive AI investment strategy [3][10] - Analysts expect Oracle's bonds to remain under pressure as the company recorded its largest stock drop in nearly 11 months [3][10] Group 6: Eli Lilly - Eli Lilly's stock rose by 3.38%, with a trading volume of $4.902 billion; the approval process for its experimental oral weight-loss drug, orforglipron, is expected to accelerate [4][11] - The potential approval date may be moved up to March 2026 from mid-May 2026, enhancing Eli Lilly's competitive position in the growing weight-loss market [4][11] Group 7: ServiceNow - ServiceNow's stock fell by 11.54%, with a trading volume of $4.555 billion; the company is in advanced talks to acquire cybersecurity startup Armis for up to $7 billion [4][11] - The deal, if completed, would be ServiceNow's largest acquisition to date, although there are risks of negotiation breakdowns or competing bids [4][11] Group 8: Strategy - Strategy's stock dropped by 8.14%, with a trading volume of $4.089 billion, following a decline in Bitcoin prices [4][12] - The CEO confirmed that the company's Bitcoin accumulation strategy is ongoing and will continue through the end of 2025 [4][12]